How to Help Your Patients Find Contrave XR in Stock: A Provider's Guide

Your Patients Can't Find Contrave XR — Here's How to Help

You've prescribed Contrave XR (Naltrexone HCl / Bupropion HCl ER) for a patient who meets the criteria for pharmacotherapy in chronic weight management. Two days later, they call your office: their pharmacy doesn't have it. Now what?

This guide walks you through practical steps to help your patients access Contrave XR — from verifying availability to leveraging manufacturer programs to considering therapeutic alternatives when necessary.

Current Availability: What's Happening with Contrave XR

Contrave XR is not in an FDA-listed shortage as of early 2026. Currax Pharmaceuticals continues to manufacture and distribute the medication. However, patients frequently report difficulty filling their prescriptions due to:

• Pharmacy stocking gaps: Many retail pharmacies don't routinely stock Contrave XR, particularly if they don't fill it frequently. Patients may need to wait 1–2 days for a special order.
• Demand increases: The ongoing GLP-1 supply constraints have driven more prescribers toward oral anti-obesity options, increasing demand for Contrave XR in some markets.
• Single-source supply: With no generic available, Contrave XR is produced by one manufacturer, leaving less flexibility in the supply chain.
• Insurance barriers: Prior authorization requirements, step therapy mandates, and formulary exclusions can create access delays that patients may report as the pharmacy "not having it."

For a detailed supply analysis, see our provider shortage briefing for 2026.

Why Patients Can't Find Contrave XR

Understanding the root cause helps you direct patients to the right solution:

The Pharmacy Doesn't Stock It

This is the most common scenario. Most pharmacies order inventory based on recent dispensing patterns. If a pharmacy fills Contrave XR infrequently, it won't appear in their automated ordering system. The solution is simple: the patient asks the pharmacy to place a special order, or you route the prescription to a pharmacy that regularly carries it.

Insurance Won't Cover It

Many commercial plans require prior authorization for Contrave XR. Medicare Part D generally excludes anti-obesity medications. If the PA is denied or the medication is non-formulary, patients may report they "can't get it" even though it's physically available. In these cases, the barrier is financial, not supply-related.

Patients Don't Know Where to Look

Patients often default to their usual pharmacy. If that pharmacy doesn't have Contrave XR, they may assume it's unavailable everywhere. Providing guidance on checking alternative pharmacies — or using availability tools — can resolve the issue quickly.

5 Steps to Help Your Patients Get Contrave XR

Step 1: Direct Patients to Medfinder

Medfinder for Providers is a free tool that shows real-time pharmacy availability for Contrave XR by location. You or your staff can:

• Search before sending the prescription to confirm a pharmacy has stock
• Provide patients with the Medfinder link so they can check availability themselves
• Use it as a workflow tool when patients call reporting access issues

This is the fastest way to match a patient with a pharmacy that has Contrave XR in stock.

Step 2: Prescribe to a CurAccess Partner Pharmacy

The CurAccess Patient Support Program from Currax Pharmaceuticals provides Contrave XR for $99/month or less with free home delivery. This program:

• Bypasses local pharmacy availability entirely
• Is available regardless of insurance status
• Uses partner pharmacies (Lombard Pharmacy, Ridgeway Pharmacy) that maintain reliable Contrave XR stock
• Simplifies the fill process — prescribe, enroll, and the medication ships to the patient

This is especially useful for patients in rural areas, those with insurance barriers, or anyone who has had repeated difficulty finding Contrave XR locally. Enrollment details are available at contravehcp.com.

Step 3: Assist with Prior Authorization

If the barrier is insurance-related, proactive PA support can make the difference:

• Document the patient's BMI, comorbidities, and prior weight management attempts in the PA request
• Note if the patient has tried or failed other therapies (step therapy documentation)
• Use Currax's Contrave Connex program for PA support resources and templates
• For commercially insured patients, the Contrave Connex Savings Card can reduce copays to as low as $30/month while the PA is being processed

Step 4: Consider Alternative Pharmacies

If the patient's usual pharmacy can't fill the prescription promptly, suggest alternatives:

• Independent pharmacies: Often have more flexible ordering and may source Contrave XR from different wholesalers
• Grocery store pharmacies: Kroger, H-E-B, Publix pharmacies may carry Contrave XR
• Costco pharmacy: Open to non-members; often competitive on brand-name pricing
• Mail-order pharmacies: If the patient's insurance includes mail-order benefits, these often have better brand-name stock

Step 5: Communicate Proactively with Your Patient

Set expectations at the point of prescribing:

• Inform patients that Contrave XR is brand-only and some pharmacies may need to order it
• Provide the CurAccess program information at the initial visit
• Suggest they use Medfinder to check availability before going to the pharmacy
• Encourage early refills (5–7 days before running out) to avoid gaps

When to Consider Alternatives

If a patient cannot access Contrave XR despite these efforts — or if cost, insurance, or clinical factors make it impractical — consider these FDA-approved alternatives:

• Qsymia (Phentermine/Topiramate ER): Oral combination; now available as generic ($30–$80/month with coupons). Good option for patients who prefer pills and need a more affordable alternative. Schedule IV controlled substance.
• Wegovy (Semaglutide 2.4 mg): Weekly GLP-1 injectable with superior weight-loss efficacy (~15% body weight). More expensive ($1,000–$1,300/month cash) and may face its own supply constraints.
• Zepbound (Tirzepatide): Weekly dual GIP/GLP-1 injectable with the highest weight-loss efficacy (~20–22% body weight). Similar cost and availability challenges as Wegovy.
• Orlistat (Xenical 120 mg / Alli 60 mg OTC): Lipase inhibitor; modest weight loss (3–5%). Non-systemic, no CNS effects. Useful for patients who can't tolerate other options.

For a detailed comparison from the patient perspective, see our post on alternatives to Contrave XR.

Workflow Tips for Your Practice

Integrating Contrave XR access support into your workflow can reduce patient callbacks and improve adherence:

• Build a pharmacy resource list. Identify 2–3 pharmacies in your area that regularly stock Contrave XR. Keep this list updated and share it with patients at prescribing.
• Bookmark Medfinder. Add medfinder.com/providers to your browser bar or EHR quick-links for rapid availability checks.
• Pre-enroll in CurAccess. Familiarize your prescribing staff with the CurAccess enrollment process so you can offer it as a first-line option, not a backup.
• Template your PA letters. Create a Contrave XR prior authorization template in your EHR with common clinical criteria pre-populated.
• Follow up on fills. At the first follow-up visit (typically 4–8 weeks), confirm the patient successfully filled and titrated. Address any access or cost issues early.

Final Thoughts

Patient access to Contrave XR in 2026 is less about supply and more about navigation. The medication is manufactured and available — but reaching the patient requires navigating pharmacy stocking practices, insurance barriers, and an increasingly crowded weight-loss market.

As a prescriber, you're in the best position to smooth this path. By using tools like Medfinder for Providers, leveraging the CurAccess program, and proactively managing insurance hurdles, you can help ensure your patients get — and stay on — the treatment you've prescribed.

For more provider resources, see our guides on the Contrave XR shortage and supply update and helping patients save money on Contrave XR.